CytomX Therapeutics (CTMX) Retained Earnings (2014 - 2026)
CytomX Therapeutics (CTMX) reported Retained Earnings of -$730.2 million for Q1 2026, down 9.29% on a YoY basis from -$805.0 million in Q1 2025, and down 2.56% quarter-over-quarter from -$711.9 million in Q4 2025.
CytomX Therapeutics (CTMX) Retained Earnings (2014 - 2026) Analysis & Trends
CytomX Therapeutics has reported Retained Earnings for 13 years, with the latest figure at -$730.2 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 9.29% year-over-year to -$730.2 million; the trailing twelve-month figure through Mar 2026 stood at -$730.2 million (down 9.29% YoY), and the FY2025 full-year result was -$711.9 million, down 2.95% from the prior year.
- Retained Earnings for Q1 2026 stood at -$730.2 million, down from -$711.9 million in the prior quarter.
- The five-year high for Retained Earnings was $104000.0 in Q3 2025, with the low at -$730.2 million in Q1 2026.
- Historically, Retained Earnings has averaged -$537.2 million across 5 years, with a median of -$691.6 million in 2024.
- The largest YoY upside for Retained Earnings was 100.01% in 2025 against a maximum downside of 16705100.0% in 2025.
- CytomX Therapeutics' Retained Earnings stood at -$722.9 million in 2022, then decreased by 0.08% to -$723.4 million in 2023, then gained by 4.41% to -$691.6 million in 2024, then slipped by 2.95% to -$711.9 million in 2025, then declined by 2.56% to -$730.2 million in 2026.
- The last three Retained Earnings figures came in at -$730.2 million (Q1 2026), -$711.9 million (Q4 2025), and $104000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | CytomX Therapeutics | 520.30 Mn | 173.59 Mn | - | -730.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -730.20 Mn |
| Dec 31, 2025 | -711.95 Mn |
| Sep 30, 2025 | 104,000.00 |
| Jun 30, 2025 | -668.21 Mn |
| Mar 31, 2025 | -668.10 Mn |
| Dec 31, 2024 | -691.58 Mn |
| Sep 30, 2024 | -710.46 Mn |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Dec 31, 2023 | -723.45 Mn |
| Sep 30, 2023 | -724.29 Mn |
| Jun 30, 2023 | -727.28 Mn |
| Mar 31, 2023 | 26,000.00 |
| Dec 31, 2022 | -722.88 Mn |
| Sep 30, 2022 | -714.10 Mn |
| Jun 30, 2022 | -685.04 Mn |
| Mar 31, 2022 | -655.54 Mn |
| Dec 31, 2021 | -623.56 Mn |
| Sep 30, 2021 | -588.74 Mn |
| Jun 30, 2021 | -557.76 Mn |